Vanda Pharmaceuticals
VNDA
VNDA
141 hedge funds and large institutions have $648M invested in Vanda Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 140 → 141 (+1)
3% less capital invested
Capital invested by funds: $672M → $648M (-$23.3M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
141
Holding in Top 10
2
Calls
$15M
Puts
$13.6M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$14.3M | |
| 3 | +$10.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.4M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.35M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$11.1M | |
| 3 | -$10.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$7.12M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$6.57M |